Defilade Capital Management, L.P.

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$712.2M
Q ending 2026-03-31
Prior quarter
$737.7M
Q ending 2025-12-31
Change
-3.5% QoQ
Positions
31
reported holdings

Largest positions

All 31 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Zimmer Biomet Holdings IncZBHShares$52.4M579K
Schein Henry IncHSICShares$46.0M624K
Becton Dickinson & CoBDXShares$43.9M279K
Pfizer IncPFEShares$41.1M1.5M
Dexcom IncDXCMShares$33.8M539K
Icu Med IncICUIShares$32.8M254K
Insmed IncINSMShares$31.9M195K
Intuitive Surgical IncISRGShares$31.2M68K
Revolution Medicines IncRVMDShares$30.7M316K
Globus Med IncGMEDShares$30.5M354K
Neurocrine Biosciences IncNBIXShares$27.7M210K
Denali Therapeutics IncDNLIShares$26.1M1.4M
Ptc Therapeutics IncPTCTShares$25.6M376K
Olema Pharmaceuticals IncOLMAShares$22.4M1.5M
Elanco Animal Health IncELANShares$22.3M931K
Pacs Group IncPACSShares$19.4M604K
Eli Lilly & CoLLYShares$19.0M21K
Lantheus Hldgs IncLNTHShares$18.9M249K
Integer Hldgs CorpITGRShares$18.7M213K
Biogen IncBIIBShares$17.7M96K
Evommune IncEVMNShares$15.6M679K
Tandem Diabetes Care IncTNDMShares$14.6M762K
Cogent Biosciences IncCOGTShares$13.6M353K
Nuvalent Inc5AXShares$13.3M130K
Ocular Therapeutix IncOCULShares$12.6M1.5M
Ascendis Pharma A/SShares$11.9M52K
Align Technology IncALGNShares$11.5M67K
Eledon Pharmaceuticals IncELDNShares$11.0M3.6M
Oric Pharmaceuticals IncORICShares$10.7M843K
Biohaven LtdShares$2.7M316K
Mereo Biopharma Group PlcMREOShares$2.5M7.6M

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.